Which are the causes of Simpson-Golabi-Behmel syndrome?

TL;DR: Simpson-Golabi-Behmel syndrome is a rare genetic condition caused by mutations or deletions in the GPC3 gene located on the X chromosome. Because it follows an X-linked inheritance pattern, the syndrome primarily affects males and results in overgrowth, distinctive facial features, and an increased risk of specific tumors.

What is the genetic cause of Simpson-Golabi-Behmel syndrome?

The primary cause of Simpson-Golabi-Behmel syndrome is a disruption of the GPC3 gene, which provides instructions for making a protein called glypican-3. Think of the GPC3 gene as a biological "brake" for cell growth; when this gene is mutated, deleted, or otherwise dysfunctional, the body loses a key mechanism that tells cells when to stop dividing. This leads to the characteristic overgrowth patterns observed in individuals with Simpson-Golabi-Behmel syndrome. Because the gene is located on the X chromosome, the condition is classified as X-linked, meaning it is passed from mothers to their sons or occurs as a spontaneous (de novo) mutation.

Is Simpson-Golabi-Behmel syndrome hereditary?

Yes, Simpson-Golabi-Behmel syndrome is considered a hereditary condition, though it can also arise from a new genetic change in an individual with no prior family history. In families where the mutation is inherited, a mother who carries the GPC3 mutation has a 50% chance of passing it to each of her children. Due to the X-linked nature of Simpson-Golabi-Behmel syndrome, males who inherit the mutation typically express the full clinical phenotype, while females who carry the mutation are often asymptomatic or exhibit much milder features due to a process called X-inactivation.

Are there environmental or other risk factors involved?

Unlike some conditions that are triggered by lifestyle or environmental exposures, Simpson-Golabi-Behmel syndrome is entirely genetic in origin. There are no known environmental triggers, infectious agents, or autoimmune processes that cause this syndrome. It is important to distinguish between "causes" and "risk factors" in this context: the cause is the specific genetic error, whereas the "risk" refers to the clinical complications associated with the syndrome, such as an increased susceptibility to embryonal tumors like Wilms tumor or hepatoblastoma.

What does current research tell us about the etiology?

Medical researchers continue to investigate the complex signaling pathways regulated by glypican-3. While the link between GPC3 and overgrowth is well-established, scientists are currently focusing on how the absence of this protein alters the Wnt signaling pathway—a critical system for embryonic development. Current research goals include:

• Mapping genotype-phenotype correlations to understand why severity varies among individuals with Simpson-Golabi-Behmel syndrome.


• Developing better surveillance protocols for early tumor detection in those with the GPC3 mutation.


• Studying the role of related genes (like GPC4) to see if they contribute to the variability of the syndrome.


• Utilizing data from the 26 members of the DiseaseMaps.org community to better document the natural history of the condition.

Next steps

• Consult a clinical geneticist to discuss genetic testing and family planning options.


• Schedule regular screenings with a pediatric oncologist, as individuals with Simpson-Golabi-Behmel syndrome require specialized monitoring for tumor development.


• Join the DiseaseMaps.org community to connect with other families and share experiences regarding the management of Simpson-Golabi-Behmel syndrome.


• Work with a multidisciplinary care team, including endocrinologists and cardiologists, to manage the multisystemic symptoms of the syndrome.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Simpson-Golabi-Behmel syndrome.


• Orphanet: Simpson-Golabi-Behmel syndrome (ORPHA:3198).


• OMIM (Online Mendelian Inheritance in Man): Simpson-Golabi-Behmel Syndrome (Entry #312870).


• PubMed: Current literature reviews on GPC3-related overgrowth syndromes.